Stay updated with breaking news from Intercept Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT)....
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NIUJ643F3FJJTGHKF6CVUQOAKM.jpg)
A panel of advisers to the U.S. Food and Drug Administration, wary of the safety of Intercept Pharmaceuticals' oral drug for a type of fatty liver disease, recommended on Friday holding off on an accelerated approval of the medicine.
The drug was in the past widely expected to become the first approved NASH therapy
This May 17 story has been corrected to say that the FDA restricted usage of drug "in" severe cirrhosis patients, not "to", in paragraph 5 The U.S. health…
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. The Dow traded up 0.31% to 33,115...